Oncology and Hematology
177-192 of 663
Komal Jhaveri, MD, FACP
- MinuteCE®
Unmet Needs in Endocrine Therapy: Rethinking the HR+/HER2- mBC Treatment Roadmap
1.00 program creditKomal Jhaveri, MD, FACP
Komal Jhaveri, MD, FACP
- MinuteCE®
Doublet or Triplet? A Case-Based Debate in First-Line Choices for HR+/HER2- mBC
1.00 program creditGiuseppe Curigliano, MD, PhD
Komal Jhaveri, MD, FACP
- MinuteCE®
Breaking Down the Benchmarks: Pivotal Data on First-Line CDK4/6 Inhibitors
1.00 program creditGiuseppe Curigliano, MD, PhD
Giuseppe Curigliano, MD, PhD
Giuseppe Curigliano, MD, PhD
Komal Jhaveri, MD, FACP
Giuseppe Curigliano, MD, PhD
Brian P. McDonough, MD, FAAFP
Charles Turck, PharmD, BCPS, BCCCP
Brian Mulherin, MD
Jennifer Caudle, DO, FACOFP
Catherine Broome, MD
Charles Turck, PharmD, BCPS, BCCCP
Hana Safah, MD
Timothy Kubal, MD
Peter Buch, MD, FACG, AGAF, FACP
Aasma Shaukat, MD, MPH
Charles Turck, PharmD, BCPS, BCCCP
Brian Mulherin, MD
Charles Turck, PharmD, BCPS, BCCCP
Jamie Koprivnikar, MD
Abdulraheem Yacoub, MD
Charles Turck, PharmD, BCPS, BCCCP
Timothy Kubal, MD
